Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

2014275 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Hepatology

Volume 61, Issue 4, pp. 777-784

Field-Weighted Citation Impact: 15.01